Doctors
A/Prof Sundaresan Puma

A/Prof Puma Sundaresan

BSC (Hons), MBBS, FRANZCR, PhD

Specialties

Radiation Oncologist

Head and Neck Cancer, Lower Gastrointestinal Cancer, Lymphoma

Academic Appointments

Clinical Associate Professor Puma Sundaresan is an experienced consultant radiation oncologist with clinical and research interests in head and neck, skin, lower gastrointestinal and haematological malignancies. She is passionate about research into health services, treatment related decision making by patients and clinicians, patient reported outcomes as well as quality of life and survivorship following cancer treatment.

Puma completed her medical training at Flinders University in Adelaide, her specialist training in radiation oncology at Westmead and Nepean Hospitals in Sydney and a postgraduate Fellowship in intracranial stereotactic radiosurgery at Sydney Radiosurgery, Royal Prince Alfred Hospital in 2009. She was appointed inaugural Dean’s Fellow at University of Sydney and clinician scientist at Royal Prince Alfred Hospital in 2011, was awarded the RANZCR Withers & Peters Fellowship Prize and the European Organisation for Research and Treatment of Cancer QOL Fellowship (2011) as well as an NHMRC PhD scholarship (2012). She was awarded a PhD, University of Sydney, in 2016. Puma returned to the Sydney West Radiation Oncology Network (Westmead and Blacktown Hospitals in NSW) in 2015 where she works as a senior staff specialist and is a member of the Head Neck, Lower GI and lymphoma MDTs. Puma also provides private radiation oncology consultations and radiation therapy services at Norwest Private and Macquarie University Hospitals.

Puma is actively involved with education, assessment, and research supervision of students at University of Sydney where she is a Clinical Academic and is a supervisor of training for radiation oncology RANZCR specialist trainees. Puma is the Chair of the Board of Directors of Head and Neck Cancer Australia, an elected Director on the Board of the Trans-Tasman Radiation Oncology Group (TROG) and a Council Member of the Clinical Oncology Society of Australia. She has served on the scientific committee of TROG (2014 – 2022), Cancer Symptom Trials Group’s Management Advisory Board (2018 – 2022) and the Radiation Oncology Research Committee of the RANZCR from 2016 – 2019. She has been an Associate Editor and reviewer for multiple international peer reviewed journals. She has convened and presented at various national / international conferences and has authored over 60 peer reviewed journal manuscripts, multiple book chapters and several International and local guidelines.

Hospitals Visited

Chris O'Brien Lifehouse
Genesis Care Macquarie